CoChat

Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice

Open access
Cantore, Alessio, Nair, Nisha, Della Valle, Patrizia, Di Matteo, Mario, Màtrai, Janka, Sanvito, Francesca, Brombin, Chiara, Di Serio, Clelia, D'Angelo, Armando, Chuah, Marinee, Naldini, Luigi, VandenDriessche, Thierry · 2012 · Blood

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Gene therapy may provide a cure for hemophilia and overcome the limitations of protein replacement therapy. Increasing the potency of gene transfer vectors may allow improvement of their therapeutic index, as lower doses can be administered to achieve therapeutic benefit, reducing toxicity of in vivo administration. Here we generated codon-usage optimized and hyperfunctional factor IX (FIX) transgenes carrying an R338L amino acid substitution (FIX Padua), previously associated with clotting hyperactivity and thrombophilia. We delivered these transgenes to hemophilia B mice by hepatocyte-targeted integration-competent and -defective lentiviral vectors. The hyperfunctional FIX transgenes increased FIX activity reconstituted in the plasma without detectable adverse effects, allowing correction of the disease phenotype at lower vector doses and resulting in improved hemostasis in vivo. The combined effect of codon optimization with the hyperactivating FIX-R338L mutation resulted in a robust 15-fold gain in potency and therefore provides a promising strategy to improve the efficacy, feasibility, and safety of hemophilia gene therapy.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2012-05-432591

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Cited by

See all 107

Metadata

Authors
Cantore, A., Nair, N., Della Valle, P., Di Matteo, M., Màtrai, J., Sanvito, F., Brombin, C., Di Serio, C., D'Angelo, A., Chuah, M., Naldini, L., & VandenDriessche, T.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • Université Libre de Bruxelles (BE)
  • Coagulation Service and Thrombosis Research Unit, San Raffaele Scientific Institute, Milan, Italy;
  • Department of Gene Therapy and Regenerative Medicine, Free University of Brussels, Brussels, Belgium;
  • IRCCS Ospedale San Raffaele (IT)
  • University Center for Statistics in the Biomedical Sciences, Vita Salute San Raffaele University, Milan, Italy
Corresponding author
  • Cantore, Alessio
  • Nair, Nisha
  • Chuah, Marinee
  • Naldini, Luigi
  • VandenDriessche, Thierry
Venue
Blood
Published
2012-11-29
Volume
120
Issue
23
Pages
4517-4520
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2063613634
Cited by
101
References
18
Citations by year
2026: 6 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 8 · 2018: 11 · 2017: 11 · 2016: 2 · 2015: 13 · 2014: 10 · 2013: 11 · 2012: 1
FWCI
7.45
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders
  • European Commission (222878)
  • Fonds Wetenschappelijk Onderzoek
  • Vrije Universiteit Brussel
Topics
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
hemophilia B, gene therapy, coagulation factor IX, codon optimization, lentiviral vectors, transgenic mice, thrombophilia, hemostasis
MeSH terms
Animals, Blood Coagulation, Hemophilia B, Dogs, Factor IX, Feasibility Studies, Genetic Vectors, Humans, Mutation, Partial Thromboplastin Time, Genetic Therapy, Lentivirus, Treatment Outcome, Amino Acid Substitution, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice. https://app.cochat.ai/papers/10.1182/blood-2012-05-432591
The paper
Cantore, A., Nair, N., Della Valle, P., Di Matteo, M., Màtrai, J., Sanvito, F., Brombin, C., Di Serio, C., D'Angelo, A., Chuah, M., Naldini, L., & VandenDriessche, T. (2012). Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice. Blood. https://doi.org/10.1182/blood-2012-05-432591

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.